Publications
-
Whitby, A, Pabla, P, Shastri, B, Amugi, L, Del Río-alvarez, A, Kim, DH, Royo, L, Armengol, C and Dandapani, M.
Characterisation of Aberrant Metabolic Pathways in Hepatoblastoma Using Liquid Chromatography and Tandem Mass Spectrometry (LC-MS/MS)
Cancers 15(21):
-
Claveria-Cabello, A, Herranz, JM, Latasa, MU, Arechederra, M, Uriarte, I, Pineda-Lucena, A, Prosper, F, Berraondo, P, Alonso, C, Sangro, B, Marin, JJG, Martinez-Chantar, ML, Ciordia, S, Corrales, FJ, Francalanci, P, Alaggio, R, Zucman-Rossi, J, Indersie, E, Cairo, S, Domingo-Sàbat, M, Zanatto, L, Sancho-Bru, P, Armengol, C, Berasain, C, Fernandez-Barrena, MG and Avila, MA.
Identification and experimental validation of druggable epigenetic targets in hepatoblastoma
Journal of Hepatology 79(4): 537-538
-
Failli, M, Demir, S, Del Río-Alvarez, A, Carrillo-Reixach, J, Royo, L, Domingo-Sàbat, M, Childs, M, Maibach, R, Alaggio, R, Czauderna, P, Morland, B, Branchereau, S, Cairo, S, Kappler, R, Armengol, C and di Bernardo, D.
Computational drug prediction in hepatoblastoma by integrating pan-cancer transcriptomics with pharmacological response
Hepatology :
-
Fang, J, Singh, S, Cheng, CD, Natarajan, S, Sheppard, H, Abu-Zaid, A, Durbin, AD, Lee, HW, Wu, Q, Steele, J, Connelly, JP, Jin, HJ, Chen, WN, Fan, YP, Pruett-Miller, SM, Rehg, JE, Koo, SC, Santiago, T, Emmons, J, Cairo, S, Wang, RN, Glazer, ES, Murphy, AJ, Chen, TS, Davidoff, AM, Armengol, C, Easton, J, Chen, X and Yang, J.
Genome-wide mapping of cancer dependency genes and genetic modifiers of chemotherapy in high-risk hepatoblastoma
Nature Communications 14(1):
-
Sanchez-Moral, L, Paul, T, Martori, C, Font-Diaz, J, Sanjurjo, L, Aran, G, Tellez, E, Blanco, J, Carrillo, J, Ito, M, Tuttolomondo, M, Ditzel, HJ, Fumagalli, C, Tapia, G, Sidorova, J, Masnou, H, Fernandez-Sanmartin, MA, Lozano, JJ, Vilaplana, C, Rodriguez-Cortes, A, Armengol, C, Valledor, AF, Kremer, L and Sarriasa, MR.
Macrophage CD5L is a target for cancer immunotherapy
EBioMedicine 91:
-
Abril-Fornaguera, J, Torrens, L, Andreu-Oller, C, Carrillo-Reixach, J, Rialdi, A, Balaseviciute, U, Pinyol, R, Montironi, C, Haber, PK, Del Rfo-Alvarez, A, Domingo-Sabat, M, Royo, L, Akers, NK, Willoughby, CE, Peix, J, Torres-Martin, M, Puigvehi, M, Cairo, S, Childs, M, Maibach, R, Alaggio, R, Czauderna, P, Morland, B, Losic, B, Mazzaferro, V, Guccione, E, Sia, D, Armengol, C and Llovet, JM.
Identification of IGF2 as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma
Molecular Cancer Therapeutics 22(4): 485-498
-
Li, Q, Demir, S, Del Rio-Alvarez, A, Maxwell, R, Wagner, A, Carrillo-Reixach, J, Armengol, C, Vokuhl, C, Haberle, B, von Schweinitz, D, Schmid, I, Cairo, S and Kappler, R.
Targeting the Unwindosome by Mebendazole Is a Vulnerability of Chemoresistant Hepatoblastoma
Cancers 14(17):
-
Corujo, D, Malinverni, R, Carrillo-Reixach, J, Meers, O, Garcia-Jaraquemada, A, Le Pannerer, MM, Valero, V, Perez, A, Del Rio-Alvarez, A, Royo, L, Perez-Gonzalez, B, Raurell, H, Acemel, RD, Santos-Pereira, JM, Garrido-Pontnou, M, Gomez-Skarmeta, JL, Pasquali, L, Manye, J, Armengol, C and Buschbeck, M.
MacroH2As regulate enhancer-promoter contacts affecting enhancer activity and sensitivity to inflammatory cytokines
Cell Reports 39(12):
-
Mosca, N, Khoubai, FZ, Fedou, S, Carrillo-Reixach, J, Caruso, S, Del Rio-Alvarez, A, Dubois, E, Avignon, C, Dugot-Senant, N, Guettier, C, Mussini, C, Zucman-Rossi, J, Armengol, C, Thiebaud, P, Veschambre, P and Grosset, CF.
LIM Homeobox-2 Suppresses Hallmarks of Adult and Pediatric Liver Cancers by Inactivating MAPK/ERK and Wnt/Beta-Catenin Pathways
Liver Cancer 11(2): 126-140
-
Farres, J, Ruiz, JL, Mas, JM, Arias, L, Sarrias, MR, Armengol, C, Cardona, PJ, Munoz-Moreno, JA, Vilaplana, M, Arranz, B, Usall, J, Serrano-Blanco, A and Vilaplana, C.
Identification of the most vulnerable populations in the psychosocial sphere: a cross-sectional study conducted in Catalonia during the strict lockdown imposed against the COVID-19 pandemic
BMJ Open 11(11):
-
Del Rio, M, Lopez-Cabrera, P, Malagon-Lopez, P, Del Cano-Aldonza, MC, Castello, JR and Provencio, M.
Effect of intravenous lidocaine on ischemia-reperfusion injury in DIEP microsurgical breast reconstruction. A prospective double-blind randomized controlled clinical trial
JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY 74(4): 809-818
-
Cairo, S, Armengol, C, Maibach, R, Haberle, B, Becker, K, Carrillo-Reixach, J, Guettier, C, Vokuhl, C, Schmid, I, Buendia, MA, Branchereau, S, von Schweinitz, D and Kappler, R.
A combined clinical and biological risk classification improves prediction of outcome in hepatoblastoma patients
European Journal of Cancer 141: 30-39
-
Carrillo-Reixach, J, Torrens, L, Simon-Coma, M, Royo, L, Domingo-Sabat, M, Abril-Fornaguera, J, Akers, N, Sala, M, Ragull, S, Arnal, M, Villalmanzo, N, Cairo, S, Villanueva, A, Kappler, R, Garrido, M, Guerra, L, Sabado, C, Guillen, G, Mallo, M, Pineyro, D, Vazquez-Vitali, M, Kuchuk, O, Mateos, ME, Ramirez, G, Santamaria, ML, Mozo, Y, Soriano, A, Grotzer, M, Branchereau, S, de Andoin, NG, Lopez-Ibor, B, Lopez-Almaraz, R, Salinas, JA, Torres, B, Hernandez, F, Uriz, JJ, Fabre, M, Blanco, J, Paris, C, Bajciova, V, Laureys, G, Masnou, H, Clos, A, Belendez, C, Guettier, C, Sumoy, L, Planas, R, Jorda, M, Nonell, L, Czauderna, P, Morland, B, Sia, D, Losic, B, Buendia, MA, Sarrias, MR, Llovet, JM and Armengol, C.
Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications
Journal of Hepatology 73(2): 328-341
-
Barcena, C, Aran, G, Perea, L, Sanjurjo, L, Tellez, E, Oncins, A, Masnou, H, Serra, I, Garcia-Gallo, M, Kremer, L, Sala, M, Armengol, C, Sancho-Bru, P and Sarrias, MR.
CD5L is a pleiotropic player in liver fibrosis controlling damage, fibrosis and immune cell content
EBioMedicine 43: 513-524
-
Aguilar-Bravo, B, Rodrigo-Torres, D, Arino, S, Coll, M, Pose, E, Blaya, D, Graupera, I, Perea, L, Vallverdu, J, Rubio-Tomas, T, Dubuquoy, L, Armengol, C, Lo Nigro, A, Starkel, P, Mathurin, P, Bataller, R, Caballeria, J, Lozano, JJ, Gines, P and Sancho-Bru, P.
Ductular Reaction Cells Display an Inflammatory Profile and Recruit Neutrophils in Alcoholic Hepatitis
Hepatology 69(5): 2180-2195